SCHEMBL12414486

SCHEMBL12414486

c1ccc(-c2ccc(N(c3ccc(-c4ccc(N(c5ccccc5)c5ccc6sc7ccccc7c6c5)cc4)cc3)c3ccc4sc5ccccc5c4c3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.45
CYP1A2 P05177 2/20 0.39
MAPT P10636 4/20 0.39
ALDH1A1 P00352 3/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PTPN7 P35236 1/20 0.38
DUSP3 P51452 1/20 0.38
PTPN12 Q05209 1/20 0.38
PTPN22 Q9Y2R2 1/20 0.38
APP P05067 1/20 0.37
TNKS O95271 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37
PIM3 Q86V86 1/20 0.37
KDM4E B2RXH2 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15306322 1.00 GPR3 (0.45) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL21425305 1.00 GPR3 (0.45) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL12414491 1.00 GPR3 (0.45) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL12414492 1.00 GPR3 (0.45) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL12414481 1.00 GPR3 (0.45) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL23172153 1.00 GPR3 (0.45) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL15964354 0.98 GPR3 (0.47) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL14295384 0.98 GPR3 (0.47) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL23172268 0.98 GPR3 (0.47) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL12414480 0.98 GPR3 (0.47) GPR3CYP1A2MAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2628778-B1 HOLE TRANSPORT MATERIALS HAVING A SULFUR-CONTAINING GROUP UNIVERSAL DISPLAY CORP (US) 2016-03-16 EP disclosed
US-8652653-B2 Hole transport materials having a sulfur-containing group UNIVERSAL DISPLAY CORPORATION (US) 2014-02-18 US disclosed
US-8652653-B2 Hole transport materials having a sulfur-containing group UNIVERSAL DISPLAY CORPORATION (US) 2014-02-18 US disclosed
EP-2628778-A1 Hole transport materials having a sulfur-containing group Universal Display Corporation (US) 2013-08-21 EP disclosed
EP-2321376-B1 HOLE TRANSPORT MATERIALS HAVING A SULFUR-CONTAINING GROUP UNIVERSAL DISPLAY CORP (US) 2013-06-19 EP disclosed
US-20110163302-A1 HOLE TRANSPORT MATERIALS HAVING A SULFUR-CONTAINING GROUP UNIVERSAL DISPLAY CORPORATION (US) 2011-07-07 US disclosed
US-20110163302-A1 HOLE TRANSPORT MATERIALS HAVING A SULFUR-CONTAINING GROUP UNIVERSAL DISPLAY CORPORATION (US) 2011-07-07 US disclosed
WO-2010002848-A1 HOLE TRANSPORT MATERIALS HAVING A SULFUR-CONTAINING GROUP UNIVERSAL DISPLAY CORPORATION (US) 2010-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110163302-A1 HOLE TRANSPORT MATERIALS HAVING A SULFUR-CONTAINING GROUP TST, SLC43A1, SLC6A4 GPR3 3600/4885CYP1A2 2135/4885MAPT 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.